Intuitive Surgical (ISRG) Slid Despite Strong Fundamentals
Intuitive Surgical (ISRG) Slid Despite Strong Fundamentals.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
NZS Capital, LLC , an investment management company, released its "NZS Growth Equity Strategy" second-quarter 2026 investor letter. A copy of the letter can be downloaded here . Equity markets delivered a strong performance in the second quarter of 2026, driven by demand for AI infrastructure, geopolitical stabilization, and positive earnings reports. The portfolio achieved a gross return of +24.96% and a net return of +24.76%, significantly outperforming the +14.79% return for the Morningstar Global Target Market Exposure Index. Overweight in Semiconductors, stock selection in areas like Software and Industrials, and zero exposure to Energy contributed to the Strategy's outperformance in the quarter. In addition, please check the Strategy's top five holdings to know its best picks in 2026.
In its Q2 2026 investor letter, NZS Growth Equity Strategy highlighted Intuitive Surgical, Inc. (NASDAQ: ISRG ). Intuitive Surgical, Inc. (NASDAQ:ISRG) is a leader in robotic-assisted surgery that develops, manufactures, and markets products for improving the quality of and access to minimally invasive care. On July 20, 2026, Intuitive Surgical, Inc. (NASDAQ:ISRG) closed at $353.17 per share. One-month return of Intuitive Surgical, Inc. (NASDAQ:ISRG) was -10.55%, and its shares lost 29.42% over the past 52 weeks. Intuitive Surgical, Inc. (NASDAQ:ISRG) has a market capitalization of $125.08 billion.
NZS Growth Equity Strategy stated the following regarding Intuitive Surgical, Inc. (NASDAQ:ISRG) in its Q2 2026 investor update:
"Only Real Estate and Healthcare contributed negatively to absolute returns, but Materials and Financials lagged. Intuitive Surgical, Inc. (NASDAQ:ISRG) was the top individual detractor to absolute returns in the quarter. While fundamentals remain solid for Intuitive Surgical, the stock's multiple has not been immune from the broad de-rating in "quality growth" stocks we've seen outside of the AI ecosystem."
Intuitive Surgical, Inc. (NASDAQ:ISRG) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 . According to our database, 103 hedge fund portfolios held Intuitive Surgical, Inc. (NASDAQ:ISRG) at the end of the first quarter, compared to 109 in the previous quarter. While we acknowledge the potential of Intuitive Surgical, Inc. (NASDAQ:ISRG) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .
In another article , we covered Intuitive Surgical, Inc. (NASDAQ:ISRG) and shared the list of worst blue chip stocks to buy. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years .
Disclosure: None. This article is originally published at Insider Monkey .
Sinergia Empresarial continuará el seguimiento de esta información sobre intuitive Surgical (ISRG) Slid Despite Strong Fundamentals y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.
